Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Modulating the BTNL2 pathway can prevent hair loss in mice.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Apremilast may help treat hair loss in alopecia areata.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

New therapies are being developed that target integrin pathways to treat various diseases.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Clonally expanded CD8+ T cells cause alopecia areata.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Blue light can help hair grow by affecting certain receptors in hair follicles.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.